26rhk149 10.3205/26rhk149 urn:nbn:de:0183-26rhk1496 Meeting Abstract Satirer Satirer Özlem Ö

University Children’s Hospital Tübingen, Tübingen, Deutschland

author Ritter Ritter Amy Jasmin AJ

University Children’s Hospital Tübingen, Tübingen, Deutschland

author Welzel Welzel Tatjana T

University Children’s Hospital Basel, Basel, Schweiz

author Benseler Benseler Susanne S

Children’s Health Ireland, Dublin, Ireland

author Kümmerle-Deschner Kümmerle-Deschner Jasmin J

University Children’s Hospital Tübingen, Tübingen, Deutschland

author German Medical Science GMS Publishing House

Düsseldorf

610 20260909 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). M0656 149 Deutsche Gesellschaft für Rheumatologie Deutsche Gesellschaft für Orthopädische Rheumatologie Gesellschaft für Kinder- und Jugendrheumatologie 54. Kongress der Deutschen Gesellschaft für Rheumatologie und Klinische Immunologie (DGRh), 36. Jahrestagung der Gesellschaft für Kinder- und Jugendrheumatologie (GKJR), 40. Jahrestagung der Deutschen Gesellschaft für Orthopädische Rheumatologie (DGORh) Deutscher Rheumatologiekongress 2026 Kinderrheumatologie Leipzig 20260909 20260912 KI.05 TextIntroduction: Autoinflammatory diseases are characterized by recurrent systemic inflammation and often substantial diagnostic delay, increasing the risk of complications. We aimed to identify clinical and healthcare-related factors associated with earlier diagnosis.Methods: This retrospective single-center study included patients with familial Mediterranean fever (FMF; rare) and cryopyrin-associated periodic syndromes (CAPS; ultra-rare). Demographic, clinical, and genetic data were analyzed. Patients were stratified by disease type, Mediterranean origin, birth cohort, and distance to the reference center. Diagnostic delay was defined as the interval between symptom onset and confirmed diagnosis.Results: A total of 146 patients were included, of whom 80% were diagnosed in childhood. Median ages at symptom onset and diagnosis were 3 and 6 years, respectively, with an overall median diagnostic delay of 4 years. CAPS accounted for 44% and FMF for 56% of cases. Median diagnostic delay was significantly shorter in FMF compared with CAPS (2 vs. 9.5 years, p<0.001). A marked temporal improvement was observed, with median delay decreasing from 24 years before 2000 to 2 years after 2010 (p<0.001). Mediterranean origin was associated with earlier diagnosis (3 vs. 13 years, p<0.001). Index-case–driven identification shortened diagnostic pathways, particularly in adults. Greater distance to the reference center was associated with a higher number of physicians consulted and longer diagnostic pathways, with patients living >100 km more frequently consulting >10 physicians compared with those living <50 km (p<0.001).Conclusion: Despite temporal improvements, diagnostic delay remains considerable. Enhancing clinical recognition, optimizing referral pathways, and integrating eHealth-based strategies may help reduce diagnostic disparities in autoinflammatory diseases.Disclosures: J.K.D. has received research grants and speaker’s fees from Novartis and SOBI. The other authors declare no conflicts of interest. Masters SL Simon A Aksentijevich I Kastner DL Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*) 2009 Annu Rev Immunol 621-68 Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol. 2009;27:621-68. DOI: 10.1146/annurev.immunol.25.022106.141627 http://dx.doi.org/10.1146/annurev.immunol.25.022106.141627 Lachmann HJ Periodic fever syndromes 2017 Best Pract Res Clin Rheumatol 596-609 Lachmann HJ. Periodic fever syndromes. Best Pract Res Clin Rheumatol. 2017 Aug;31(4):596-609. DOI: 10.1016/j.berh.2017.12.001 http://dx.doi.org/10.1016/j.berh.2017.12.001 Toplak N Frenkel J Ozen S Lachmann HJ Woo P Koné-Paut I De Benedetti F Neven B Hofer M Dolezalova P Kümmerle-Deschner J Touitou I Hentgen V Simon A Girschick H Rose C Wouters C Vesely R Arostegui J Stojanov S Ozgodan H Martini A Ruperto N Gattorno M Paediatric Rheumatology International Trials Organisation (PRINTO) Eurotraps and Eurofever Projects An international registry on autoinflammatory diseases: the Eurofever experience 2012 Ann Rheum Dis 1177-82 Toplak N, Frenkel J, Ozen S, Lachmann HJ, Woo P, Koné-Paut I, De Benedetti F, Neven B, Hofer M, Dolezalova P, Kümmerle-Deschner J, Touitou I, Hentgen V, Simon A, Girschick H, Rose C, Wouters C, Vesely R, Arostegui J, Stojanov S, Ozgodan H, Martini A, Ruperto N, Gattorno M; Paediatric Rheumatology International Trials Organisation (PRINTO), Eurotraps and Eurofever Projects. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012 Jul;71(7):1177-82. DOI: 10.1136/annrheumdis-2011-200549 http://dx.doi.org/10.1136/annrheumdis-2011-200549 Church LD Savic S McDermott MF Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap) 2008 Biologics 733-42 Church LD, Savic S, McDermott MF. Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap). Biologics. 2008 Dec;2(4):733-42. DOI: 10.2147/btt.s3167 http://dx.doi.org/10.2147/btt.s3167 Meinzer U Quartier P Alexandra JF Hentgen V Retornaz F Koné-Paut I Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature 2011 Semin Arthritis Rheum 265-71 Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Koné-Paut I. Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum. 2011 Oct;41(2):265-71. DOI: 10.1016/j.semarthrit.2010.11.003 http://dx.doi.org/10.1016/j.semarthrit.2010.11.003 ter Haar NM Oswald M Jeyaratnam J Anton J Barron KS Brogan PA Cantarini L Galeotti C Grateau G Hentgen V Hofer M Kallinich T Kone-Paut I Lachmann HJ Ozdogan H Ozen S Russo R Simon A Uziel Y Wouters C Feldman BM Vastert SJ Wulffraat NM Benseler SM Frenkel J Gattorno M Kuemmerle-Deschner JB Recommendations for the management of autoinflammatory diseases 2015 Ann Rheum Dis 1636-44 ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, Cantarini L, Galeotti C, Grateau G, Hentgen V, Hofer M, Kallinich T, Kone-Paut I, Lachmann HJ, Ozdogan H, Ozen S, Russo R, Simon A, Uziel Y, Wouters C, Feldman BM, Vastert SJ, Wulffraat NM, Benseler SM, Frenkel J, Gattorno M, Kuemmerle-Deschner JB. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015 Sep;74(9):1636-44. DOI: 10.1136/annrheumdis-2015-207546 http://dx.doi.org/10.1136/annrheumdis-2015-207546 Erdogan M Ugurlu S Ozdogan H Seyahi E Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey 2019 Clin Exp Rheumatol 119-124 Erdogan M, Ugurlu S, Ozdogan H, Seyahi E. Familial Mediterranean fever: misdiagnosis and diagnostic delay in Turkey. Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):119-124. Schnappauf O Aksentijevich I Current and future advances in genetic testing in systemic autoinflammatory diseases 2019 Rheumatology (Oxford) vi44-vi55 Schnappauf O, Aksentijevich I. Current and future advances in genetic testing in systemic autoinflammatory diseases. Rheumatology (Oxford). 2019 Nov 1;58(Suppl 6):vi44-vi55. DOI: 10.1093/rheumatology/kez294 http://dx.doi.org/10.1093/rheumatology/kez294 0 0 0 0